https://koreaaestheticjournal.com/ Clinical reading of aesthetic medicine in Korea en https://koreaaestheticjournal.com/pdlla-vs-sculptra-pla-clinical-comparison-2026/ https://koreaaestheticjournal.com/pdlla-vs-sculptra-pla-clinical-comparison-2026/ A journal-of-medicine reading of the two principal poly-lactic-acid biostimulators in 2026 — Juvelook (PDLLA, VAIM Global, MFDS-cleared 2020) and Sculptra (PLLA, Galderma, US FDA 1999) — across molecular weight, microsphere geometry, dilution protocol, session count, and the way senior Korean houses 2026-05-25T11:00:00Z https://koreaaestheticjournal.com/botulinum-toxin-type-a-korean-brands-clinical-survey/ https://koreaaestheticjournal.com/botulinum-toxin-type-a-korean-brands-clinical-survey/ A journal-of-medicine reading of the Korean botulinum toxin type-A landscape in 2026 — what MFDS clearance distinguishes between Hutox, Nabota, Coretox, Meditoxin, Wonder-Tox, and Liztox, and how the senior Seoul houses sequence the unit count, the dilution, and the four-week review around an intern 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/korean-aesthetic-medicine-statistics-survey-2026/ https://koreaaestheticjournal.com/korean-aesthetic-medicine-statistics-survey-2026/ A clinical-evidence reading of the Korean aesthetic-medicine landscape through KHIDI medical-tourism receipts, MFDS device clearance counts, MOHW physician licensure, and the procedure-category share that the senior Seoul houses translate into daily case-note discipline. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/korean-aesthetic-medicine-decade-clinical-retrospective-2026/ https://koreaaestheticjournal.com/korean-aesthetic-medicine-decade-clinical-retrospective-2026/ A journal-of-medicine reading of Korea's aesthetic-medicine decade — Rejuran 2014, Ultherapy 2015, Juvelook 2020, ASCE+ exosome 2024 — against MFDS clearance, the published Korean clinical record, and the 2026 senior-house consensus an international reader can actually plan a trip around. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/korean-laser-clinical-evidence-survey-2026/ https://koreaaestheticjournal.com/korean-laser-clinical-evidence-survey-2026/ A clinical-evidence reading of the Korean laser landscape — picosecond, fractional CO2, IPL, pulsed-dye, Q-switched, and carbon toning — through the lens of MFDS device class, KSLMS consensus, and the senior Korean dermatology houses that translate the literature into routine practice. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/downtime-by-procedure-clinical-survey-2026/ https://koreaaestheticjournal.com/downtime-by-procedure-clinical-survey-2026/ A journal-of-medicine reading of what aesthetic-procedure downtime actually looks like in Seoul in 2026 — by procedure category, by recovery milestone, and by the calendar a serious international traveller would build a Korean visit around. 2026-05-25T11:00:00Z https://koreaaestheticjournal.com/juvelook-pdlla-mfu-combination-clinical-reading/ https://koreaaestheticjournal.com/juvelook-pdlla-mfu-combination-clinical-reading/ A journal-of-medicine reading of the Juvelook PDLLA microsphere booster stacked with microfocused ultrasound lifting in Korea in 2026 — what the published literature actually shows about the layered protocol, what the MFDS clearance record permits, and how senior Seoul houses sequence biostimulation 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/post-pico-laser-recovery-clinical-protocol-2026/ https://koreaaestheticjournal.com/post-pico-laser-recovery-clinical-protocol-2026/ Picosecond laser delivery is brief; the recovery curve is not. The first seventy-two hours decide barrier comfort, the second week decides crust resolution, and the third-week-onward window decides whether post-inflammatory hyperpigmentation will read on the editorial photograph at ninety days. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/rejuran-vs-plinest-polynucleotide-clinical-comparison-2026/ https://koreaaestheticjournal.com/rejuran-vs-plinest-polynucleotide-clinical-comparison-2026/ A journal-of-medicine reading of the two anchor polynucleotide skin boosters available in Korea in 2026 — Rejuran from Pharma Research and Plinest from Mastelli — with attention to molecular source, polymer weight, MFDS clearance, and how senior Seoul houses sequence each protocol at the chair. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/non-surgical-nose-augmentation-clinical-reading-2026/ https://koreaaestheticjournal.com/non-surgical-nose-augmentation-clinical-reading-2026/ A clinical-literature reading of non-surgical nose augmentation as practised in Korean clinics in 2026 — what the dorsum, tip, and columellar protocols actually do, what the vascular-safety record looks like, and what the regulatory and consent picture is for an international patient. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/photoaging-recovery-clinical-protocol-2026/ https://koreaaestheticjournal.com/photoaging-recovery-clinical-protocol-2026/ Photoaging is a slow accumulation read across decades — dyschromia, solar elastosis, telangiectasia, deep rhytides. The recovery protocol that reads most reliably is the one a senior Korean house has staged against the Glogau scale rather than against a single device. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/lifting-device-grade-system-korea-2026/ https://koreaaestheticjournal.com/lifting-device-grade-system-korea-2026/ An editorial reading of how Korean regulators stratify lifting devices — Class II versus Class III medical-device clearance, energy modality, depth, and what the grade actually means for a senior Korean clinical protocol. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/carbon-laser-q-switch-clinical-device-categorization-2026/ https://koreaaestheticjournal.com/carbon-laser-q-switch-clinical-device-categorization-2026/ Carbon-laser toning rests on a quiet pulse-duration distinction — Q-switched Nd:YAG nanosecond at 1064 nm versus picosecond 1064 nm — and the Korean clinical literature reads the two as mechanistically related but operationally separate device classes. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/dryness-and-barrier-recovery-clinical-protocol-2026/ https://koreaaestheticjournal.com/dryness-and-barrier-recovery-clinical-protocol-2026/ Persistent dryness after a procedure, after a flight, or after months of compromised barrier function is not one condition but four — each with its own biomarker, its own clinical sign, and its own evidence-graded intervention. The clinical literature reads barrier recovery as overlapping repair com 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/dermal-filler-device-categorization-clinical-2026/ https://koreaaestheticjournal.com/dermal-filler-device-categorization-clinical-2026/ A clinical reading of hyaluronic-acid dermal filler device technology — cross-link platform, G' rheology, duration, and MFDS class — written for the reader who reads the device clearance dossier before the brochure, and the Seoul houses that translate that grammar. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/post-mfu-recovery-clinical-protocol-2026/ https://koreaaestheticjournal.com/post-mfu-recovery-clinical-protocol-2026/ Micro-focused ultrasound delivers its visible result on a 90-to-180-day collagen timetable — yet the recovery phase that reads most reliably is the one a Korean senior house has rehearsed many times. The clinical literature reads recovery as five overlapping windows, each with its own biomarker. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/hydrodermabrasion-aqua-peel-clinical-categorization/ https://koreaaestheticjournal.com/hydrodermabrasion-aqua-peel-clinical-categorization/ Hydrodermabrasion, often marketed in Korea as aqua peel, hydro peel, or hydrafacial, is a category of vacuum-assisted serum-infusion devices that exfoliate the stratum corneum while delivering aqueous serums into the upper dermis. The clinical literature reads four distinct platforms in this categor 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/rf-microneedling-device-categorization-clinical-2026/ https://koreaaestheticjournal.com/rf-microneedling-device-categorization-clinical-2026/ An editorial reading of Korea's RF microneedling cohort — six platforms separated less by marketing copy than by pulse architecture, insulation strategy, tip geometry, and the MFDS regulatory dossier that cleared each one. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/energy-based-device-survey-clinical-2026/ https://koreaaestheticjournal.com/energy-based-device-survey-clinical-2026/ An editorial survey of the seven energy-based device categories in Korean clinical practice — MFU, monopolar RF, bipolar RF, fractional laser, pico laser, IPL, and LED — read by MFDS class, energy principle, target depth, and primary indication. 2026-05-25T10:00:00Z https://koreaaestheticjournal.com/post-injection-bruising-vascular-clinical-reading-2026/ https://koreaaestheticjournal.com/post-injection-bruising-vascular-clinical-reading-2026/ A journal-of-medicine reading of the post-injection complication spectrum in Korea in 2026 — what the published literature describes about routine bruising, Tyndall effect, vascular occlusion, and impending necrosis, and how senior Seoul houses script the hyaluronidase, nitroglycerin, and antibiotic 2026-05-25T10:00:00Z